You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Yao S, Ambrosone CB, Sakoda L, et al
490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0490